Published in J Interferon Res on January 01, 1985
Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2. Pharmaceuticals (Basel) (2010) 0.75
Antinociceptive activity of Stephanolepis hispidus skin aqueous extract depends partly on opioid system activation. Mar Drugs (2013) 0.75
Oromucosal Administration of Interferon to Humans. Pharmaceuticals (Basel) (2010) 0.75
Evidence of functional lymphocytes in some (leaky) scid mice. J Exp Med (1988) 3.09
Mutant immunoglobulin genes have repetitive DNA elements inserted into their intervening sequences. Proc Natl Acad Sci U S A (1982) 2.44
Pharmacodynamic effects and pharmacokinetics of atorvastatin after administration to normocholesterolemic subjects in the morning and evening. J Clin Pharmacol (1996) 2.37
Evidence for close linkage of a mouse light chain marker with the Ly-2,3 locus. J Immunol (1978) 2.34
Symposium on microbial changes in foods. Bacteria active in the spoilage of certain sea foods. J Appl Bacteriol (1971) 2.01
Radioimmunoassay for prednisolone. Steroids (1973) 1.81
Taxonomic position and seasonal variations in marine neritic environment of some gram-negative antibiotic-producing bacteria. J Gen Microbiol (1975) 1.74
Adult living donor liver transplantation: Preferences about donation outside the medical community. Liver Transpl (2001) 1.59
Short-term effects of insulin and glucagon on lipid synthesis in isolated rat hepatocytes. Covariance of acetyl-CoA carboxylase activity and the rate of 3H2O incorporation into fatty acids. FEBS Lett (1978) 1.59
Protein phosphatase 2A subunit assembly: the catalytic subunit carboxy terminus is important for binding cellular B subunit but not polyomavirus middle tumor antigen. Oncogene (1997) 1.57
Sequence diversity within a subgroup of mouse immunoglobulin kappa chains controlled by the IgK-Ef2 locus. J Exp Med (1981) 1.55
Extracellular phytase (E.C. 3.1.3.8) from Aspergillus ficuum NRRL 3135: purification and characterization. Prep Biochem (1987) 1.54
Electronic measurement of bacterial growth. J Phys E (1978) 1.50
Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects. Clin Pharmacol Ther (1996) 1.48
The kinetics of taxoid accumulation in cell suspension cultures of Taxus following elicitation with methyl jasmonate. Biotechnol Bioeng (1999) 1.44
Surrogate biochemical markers: precise measurement for strategic drug and biologics development. J Clin Pharmacol (1995) 1.43
Tuberculosis Prevention. Can Med Assoc J (1945) 1.38
Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and wth protein fractions of rat liver cytosol. Biochem Biophys Res Commun (1973) 1.38
Estimating the accumulation of drugs. J Pharm Sci (1983) 1.37
Cytochrome P450-catalyzed hydroxylation of taxa-4(5),11(12)-diene to taxa-4(20),11(12)-dien-5alpha-ol: the first oxygenation step in taxol biosynthesis. Chem Biol (1996) 1.34
Purification and properties of a novel cytochrome: flavocytochrome c from Shewanella putrefaciens. Biochem J (1994) 1.33
The txtAB genes of the plant pathogen Streptomyces acidiscabies encode a peptide synthetase required for phytotoxin thaxtomin A production and pathogenicity. Mol Microbiol (2000) 1.30
Reversible modulation of the activities of both liver microsomal hydroxymethylglutaryl coenzyme A reductase and its inactivating enzyme. Evidence for regulation by phosphorylation-dephosphorylation. Biochem Biophys Res Commun (1978) 1.29
A device for recording automatic audio tape recording. J Appl Behav Anal (1971) 1.24
Single- and multiple-dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers. Br J Clin Pharmacol (2000) 1.23
Serum glycoproteins in cancer patients: first report of correlations with in vitro and in vivo parameters of cellular immunity. Cancer (1980) 1.22
Modulation of hydroxymethylglutaryl-CoA reductase activity, reductase kinase activity, and cholesterol synthesis in rat hepatocytes in response to insulin and glucagon. J Biol Chem (1979) 1.19
A guanosine triphosphate-dependent acyl coenzyme A synthetase from rat liver mitochondria. J Biol Chem (1967) 1.19
Inhibition of hyperlipogenesis with puromycin or actinomycin D. Biochim Biophys Acta (1965) 1.18
Phosphorylation of native 97-kDa 3-hydroxy-3-methylglutaryl-coenzyme A reductase from rat liver. Impact on activity and degradation of the enzyme. J Biol Chem (1989) 1.17
Subcellular Localizations of Two Dolichos biflorus Lectins. Plant Physiol (1984) 1.15
Characterizing hepatitis B stigma in Chinese immigrants. J Viral Hepat (2011) 1.13
Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther (1987) 1.13
Simultaneous pharmacokinetic and pharmacodynamic modeling. J Pharmacokinet Biopharm (1981) 1.13
The effects of desmethylimipramine on uptake of dl-norepinephrine-7-H3 in the heart. J Pharmacol Exp Ther (1966) 1.12
Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects. J Pharmacokinet Biopharm (1977) 1.12
Reversible modulation of liver hydroxymethylglutaryl CoA reductase. Life Sci (1978) 1.11
Plasma protein binding of diazepam after a single dose of sodium oleate. J Pharm Sci (1978) 1.10
Antibody gene linkage studies in (NZB X C58) recombinant-inbred lines. J Immunol (1980) 1.09
Microbiological quality and shelf life prediction of chilled fish. Int J Food Microbiol (1988) 1.07
Synthesis and degradation of the lipogenic enzymes of rat liver. Adv Enzyme Regul (1972) 1.06
Purification and characterization of acid phosphatase from cotyledons of germinating soybean seeds. Arch Biochem Biophys (1988) 1.06
Influence of respiratory substrate on the cytochrome content of Shewanella putrefaciens. FEMS Microbiol Lett (1990) 1.05
Pharmacokinetic/pharmacodynamic modeling in drug research and development. J Clin Pharmacol (2000) 1.04
Patients' values for health states associated with hepatitis C and physicians' estimates of those values. Am J Gastroenterol (2001) 1.04
Pharmacokinetics of erythromycin on repetitive dosing. J Clin Pharmacol (1977) 1.04
Biopharmaceutical and clinical pharmacokinetic profile of bromazepam. J Pharmacokinet Biopharm (1976) 0.99
Interaction of chloramphenicol with phenytoin and phenobarbital. Case report. Clin Pharmacol Ther (1978) 0.98
Dose dependent pharmacokinetics of midazolam. Eur J Clin Pharmacol (1985) 0.97
Ef2: a new LY-3-linked light-chain marker expressed in normal mouse serum immunoglobulin. J Exp Med (1979) 0.96
Food increases the bioavailability of isotretinoin. J Clin Pharmacol (1984) 0.96
Evidence for 65 electrophoretically distinct groups of light chains in BALB/c and NZB myelomas. Mol Immunol (1984) 0.96
Iturin levels on wheat spikes linked to biological control of Fusarium head blight by Bacillus amyloliquefaciens. Phytopathology (2013) 0.96
Deletions in immunoglobulin polypeptide chains as evidence for breakage and repair in DNA. Science (1971) 0.96
Pharmacokinetic profile of trimethoprim in dog and man. J Pharm Sci (1970) 0.96
Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin Pharmacol Ther (1990) 0.96
Phosphorylation of microsomal HMG CoA reductase increases susceptibility to proteolytic degradation in vitro. Biochem Biophys Res Commun (1984) 0.95
Involvement of a cytochrome P450 monooxygenase in thaxtomin A biosynthesis by Streptomyces acidiscabies. J Bacteriol (2002) 0.94
A simple method for enhancing paclitaxel release from Taxus canadensis cell suspension cultures utilizing cell wall digesting enzymes. Plant Cell Rep (2003) 0.92
Phosphorylation and degradation of HMG CoA reductase. Adv Enzyme Regul (1989) 0.92
Limited clonal diversity of serum immunoglobulin in leaky scid mice. Curr Top Microbiol Immunol (1989) 0.92
The Potential of Thiarubrine C as a Nematicidal Agent against Plant- parasitic Nematodes. J Nematol (1998) 0.92
The organization of immunoglobulin variable kappa chain genes on mouse chromosome 6. Immunogenetics (1986) 0.92
Renal clearance of carprofen in the isolated perfused rat kidney. Drug Metab Dispos (1981) 0.91
Pharmacokinetic and biopharmaceutic profile of chlordiazepoxide HC1 in healthy subjects: single-dose studies by the intravenous, intramuscular, and oral routes. J Pharmacokinet Biopharm (1977) 0.91
Regulation of liver hydroxymethylglutaryl-CoA reductase by a bicyclic phosphorylation system. J Biol Chem (1981) 0.91
Positive identification of a lambda gt11 clone containing a region of fungal phytase gene by immunoprobe and sequence verification. Appl Microbiol Biotechnol (1991) 0.90
Oxidation of long chain fatty acids by rat liver mitochondria. J Biol Chem (1967) 0.90
Interaction and well-being in old age: is it quantity or quality that counts? Int J Aging Hum Dev (1987) 0.90
A major group of mouse kappa chains controlled by the chromosome 6 locus, IgK-Ef2. J Exp Med (1980) 0.90
Influence of lecithin on the activity of the GTP-dependent acyl-coA synthetase. Biochem Biophys Res Commun (1967) 0.89
Characterization of allelic V kappa-1 region genes in inbred strains of mice. J Immunol (1989) 0.89
Short-term regulation of hydroxymethylglutaryl coenzyme A reductase by reversible phosphorylation: modulation of reductase phosphatase in rat hepatocytes. Adv Enzyme Regul (1982) 0.89
A rapid method for purifying bacterial deoxyribonucleic acid. J Appl Bacteriol (1979) 0.88
Pharmacokinetic model for diazepam and its major metabolite desmethyldiazepam following diazepam administration. J Pharm Sci (1983) 0.88
Ethnic differences in the presentation of chronic hepatitis C. J Viral Hepat (2006) 0.88
Unique V kappa group associated with two mouse L chain genetic markers. Proc Natl Acad Sci U S A (1981) 0.88
Intraabdominal abscess after penetrating abdominal trauma. Am J Surg (1981) 0.88
Selective dampening of lipogenic enzymes of liver by exogenous polyunsaturated fatty acids. Biochem Biophys Res Commun (1970) 0.88
Determination of quinapril and its active metabolite in human plasma and urine by gas chromatography with electron-capture detection. J Chromatogr (1987) 0.88
Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection. Clin Pharmacol Ther (1984) 0.88
Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene. Clin Pharmacol Ther (1982) 0.87
An evolution of drug development and clinical pharmacology during the 20th century. J Clin Pharmacol (2000) 0.87
Relative and absolute bioavailability of prednisone and prednisolone after separate oral and intravenous doses. J Clin Pharmacol (1988) 0.86
Lipid Composition of Cyst Stages of Globodera rostochiensis. J Nematol (1995) 0.86
Serum glycoproteins and immunoglobulins in nasopharyngeal carcinoma: correlations with Epstein-Barr virus associated antibodies and clinical tumor stage. Am J Surg (1979) 0.86
Effect of food on the pharmacodynamics and pharmacokinetics of atorvastatin, an inhibitor of HMG-CoA reductase. Eur J Drug Metab Pharmacokinet (2001) 0.86
The clinical pharmacokinetics of quinapril. Angiology (1989) 0.86
A new radioimmunoassay for haloperidol: direct measurement of serum and striatal concentrations. J Pharmacol Exp Ther (1981) 0.85
The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon. J Infect Dis (2000) 0.85
Polymorphism of kappa variable region (V kappa-1) genes in inbred mice: relationship to the Ig kappa-Ef2 serum light chain marker. J Immunol (1985) 0.85
Taxol production and taxadiene synthase activity in Taxus canadensis cell suspension cultures. Arch Biochem Biophys (1997) 0.84
Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit Care Med (1996) 0.84
Continuing evaluation of the Queen's University tactile vocoder II: Identification of open set sentences and tracking narrative. J Rehabil Res Dev (1986) 0.84
Light chain isotype regulation in the horse. Characterization of Ig kappa genes. J Immunol (1994) 0.84
Isolation of labeled 9-dihydrobaccatin III and related taxoids from cell cultures of taxuscell cultures of taxus canadensis elicited with m. J Nat Prod (1999) 0.83
Influence of food on the pharmacokinetics of quinapril and its active diacid metabolite, CI-928. J Clin Pharmacol (1988) 0.83
Clinical pharmacokinetics of the retinoids. Clin Pharmacokinet (1985) 0.83